Health In Tech, Inc. HIT
At closeNov 5, 2026, 4:00 PM EST
After hours · Nov 5, 4:00 PM ET
Day range unavailable
- YTD
- -63.75%
- 1 year
- -79.78%
- Market cap
- 37.64M
- Revenue (ttm)
- 19.80M
- Profit margin
- 9.18%
- EPS (ttm)
- -0.07
- Shares out
- 54.07M
- YTD return
- -63.75%
- 1-year return
- -79.78%
- Avg volume
- 176.00K
- Previous close
- 0.5764
- 52-week range
- 0.492 – 3.05
5D -0.0536 (-8.51%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 13.93
- Price / book
- 38.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -14.90%
- Free cash flow
- 0
- Total cash
- 1.75M
- Total debt
- 222.29K
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Health In Tech, Inc.
Health In Tech, Inc. operates as an insurance technology platform company. It offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. The company also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 1964 and is based in Stuart, Florida.
- Sector
- Technology
- Industry
- Software - Application
- Country
- United States
- Website
- healthintech.com
News
Health In Tech Registers Up To 34,224,247 Shares Of Class A Common Stock For Yorkville Resale Under $20M Standby Equity Purchase Agreement
Health In Tech Rolls Out AI-Powered HitRix
12 Financials Stocks Moving In Thursday's Pre-Market Session Health In Tech Rolls Out AI-Powered Platform HitRix; Expects FY26 Revenue To Be ~$33M
Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3
Health In Tech Q2 2026 Earnings Call: Complete Transcript Health In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.813M Est
Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate
Health In Tech Added To Russell Microcap Index On June 29
Health In Tech May Offer Up To $300M In Common And Preferred Stock, Warrants, Debt, Rights, And Units
Your note
Sign in to keep a note on HIT — it syncs with the Stock Master app.
